Abortion pill maker sues FDA to preserve access

Abortion pill maker sues FDA to preserve access

[ad_1] A ruling by the 5th Circuit Court of Appeals now pending before the Supreme Court would unwind policies the FDA has approved since 2016 to make the abortion pill more accessible — including telemedicine prescription, mail delivery and retail pharmacy dispensing — and shrink the window of time patients are approved by FDA to…

Read More
Alito keeps access to abortion pill unchanged for next five days while Supreme Court reviews emergency appeals

Alito keeps access to abortion pill unchanged for next five days while Supreme Court reviews emergency appeals

[ad_1] The appeals court ruling — if it takes effect — would suspend several policies the FDA has approved since 2016 to make mifepristone more accessible, including telemedicine prescription, mail delivery and retail pharmacy dispensing. The ruling also would suspend approval of the generic version of the drug and would narrow the window of time…

Read More
Back To Top